Evaluación del impacto epidemiológico y económico de las vacunas para COVID-19 según comorbilidad y nivel socioeconómico en el País Vasco
Four COVID-19 vaccines are currently on the market (P zer / BioNTech, Moderna, Oxford-Astrazeneca and Janssen). It is necessary to assess the epidemiological and economic impact of the vaccination process. This requires the use of dynamic models that take into account the herd e ect. Comorbidity and socioeconomic status are associated with the risks associated with COVID-19 infection. The objective of this project is to carry out an evaluation of the epidemiological and economic impact of the vaccination program for COVID-19 in Osakidetza according to comorbidity and socioeconomic level.